Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Circular RNA Translation Modulation via Small Ligand-Mediated Protein Stabilization.

Created on 18 Aug 2026

Authors

Hua Li, Kehui Xin, Li-Juan Tang, Fenglin Wang, Jian-Hui Jiang

Published in

Analytical chemistry. Volume 98. Issue 32. Pages 23819-23826. Aug 18, 2026.

Abstract

Circular RNAs (circRNAs) have emerged as a promising platform for RNA-based therapeutics, ascribed to their excellent stability and prolonged protein translation capacity. However, modulation of circRNA translation remains a great challenge. Here, we develop a new chemically regulated circRNA translation system based on small ligand-induced stabilization of RNA-binding proteins (RBPs). The system is engineered by incorporating RNA motifs into an internal ribosomal entry site and fusing RBPs with small ligand-stabilized conditional proteins. We show that this design allows small ligand-modulated translation of circRNAs with a wide dynamic range and dose dependency. It is demonstrated that this strategy is modular and versatile to different RBPs and small-ligand-stabilized conditional proteins. We further employ this strategy to control the translation of functional proteins, including a guanine nucleotide exchange factor for modulating signaling pathways and a bispecific engager for regulating T cell activities. This system is highly modular and versatile, highlighting its great potential for basic research and therapeutic applications.

PMID:
42610922
Bibliographic data and abstract were imported from PubMed on 18 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement